Better Synthetic Biology Stock: Amyris vs. Codexis

Both stocks have gained over 140% in the last year alone. Both are looking forward to growth from innovative sweetener ingredients. One doesn't belong in your portfolio.
These plans are more geared towards making budgetary numbers add up than fundamental welfare reform. from BBC News https://ift.tt/KvsI9qx ...
0 comments:
Post a Comment